What question did this study set out to answer?

The primary aim is to assess the quality and effectiveness of preventive activities for early detection of type 2 diabetes mellitus in 2022-2023.

Problems in organizing dispensary follow-up of patients with type 2 diabetes mellitus

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial evaluates quality of dispensary follow-up in patients with type 2 diabetes, indicating vital areas for improvement.

The primary aim is to assess the quality and effectiveness of preventive activities for early detection of type 2 diabetes mellitus in 2022-2023.
Analysis of official statistical data and reporting forms No. 131/o and No. 12
Review of 500 outpatient medical records and 100 records of deceased patients
Focus on detection rates, mortality rates, quality of follow-up, and compliance with standards.
Detection rate of type 2 diabetes during check-ups increased from 1.02 to 1.61 per 1.000 individuals examined (2022-2023) albeit lower than national average.
Enrolment in dispensary follow-up improved from 85.5% to 90.3%, still below the national rate of 97.1%.
Mortality rate increased by 27%, with a 28% rise among working-age individuals, indicating significant health concerns.

Ponomarev et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark